Advances in Drug Discovery 2017

6 March 2017 08:00 - 7 March 2017 17:15, Cambridge, United Kingdom

Introduction

With over 300 attendees expected, this multi-track event builds on the success of our Cambridge Workshop Series and will feature four tracks:

Epigenetics in Drug Discovery
Antibodies in Drug Discovery
Academic Drug Discovery
Stem Cells in Drug Discovery

As a multi-track event, delegates will have unrestricted access to all conference tracks and networking opportunities. If you are looking to hear from the experts; learn new skills; discover new ideas, trends & concepts; Advances in Drug Discovery 2017 is not to be missed.

Keynote Speakers:

Rakesh Dixit
Vice President/Global Head, MedImmune Inc

Michelle Arkin
Director of the Small Molecule Discovery Center, University of California San Francisco

Ludovic Vallier
Professor, University Of Cambridge

Stefan Knapp
Professor, Goethe Institut Franfurt

James Audia
Chief Scientific Officer, Constellation Pharmaceuticals

Sir Alan Fersht
Professor, MRC Laboratory of Molecular Biology

Christine Mummery
Professor and Chair of Developmental Biology, Leiden University Medical Centre

Sally Ward
Professor, Texas A&M Health Science Center

Danica Fujimori
Principal Investigator, University of California, San Francisco

Paul Workman
Chief Executive and President, Institute of Cancer Research, London

Dafydd Owen
Associate Research Fellow, Pfizer Ltd